Display options
Share it on

Ann Transl Med. 2016 Jul;4(13):257. doi: 10.21037/atm.2016.07.04.

High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages.

Annals of translational medicine

Claudio Galli, Giuseppe Lippi

Affiliations

  1. Medical Scientific Liaison Europe, Abbott Diagnostics, Roma, Italy ;
  2. Section of Clinical Biochemistry, University of Verona, Verona, Italy.

PMID: 27500158 PMCID: PMC4958731 DOI: 10.21037/atm.2016.07.04

Abstract

Very seldom, if ever, a single laboratory test has provided such a paradigm shift in the managed care as cardiac troponin (cTn) testing. More than twenty years of improvements in test design and analytical features have contributed to revolutionize the clinical recommendations and guidelines, and the diagnosis of myocardial infarction (MI) is now highly dependent upon the kinetics of cTn within a suggestive clinical setting. Despite the advent of high-sensitivity cTn (HS-cTn) immunoassays has allowed a more accurate and timely diagnosis as well as a higher prognostic accuracy, the focus is now shifting on the most suitable algorithms and on a comprehensive approach to the clinical management of acute coronary syndrome (ACS). In this article we aim to discuss the implications of HS-cTn testing for ruling out and ruling in ACS. In the latter instance, main improvements are related to ACS diagnosis in women, in whom this pathology is still often underdiagnosed or misdiagnosed. A quick and accurate rule out will also regarded as a great advantage from both an organizational and economic standpoint. The advantages that will stem from this new approach have been recently assessed, and shortening of repeated testing 1 or 2 h from conventional algorithms entailing blood sampling at 3 and 6 h seems attainable. The larger benefits will definitely occur in clinical settings where the actual diagnosis rate of MI among patients with suspect ACS is lower and, consequently, the negative predictive value (NPV) of HS-cTn is the highest.

Keywords: Cardiac troponin I (cTnI); emergency room; health technology assessment; major adverse events; myocardial infarction (MI)

References

  1. Clin Chem. 1999 Jul;45(7):1104-21 - PubMed
  2. Clin Chem. 2014 Mar;60(3):455-62 - PubMed
  3. Clin Chem Lab Med. 2013 Sep;51(9):1727-37 - PubMed
  4. Clin Chem. 1992 Nov;38(11):2203-14 - PubMed
  5. JAMA Cardiol. 2016 Jul 1;1(4):397-404 - PubMed
  6. Eur Heart J. 2016 Jan 14;37(3):221-8 - PubMed
  7. Ann Emerg Med. 2006 Dec;48(6):666-77, 677.e1-9 - PubMed
  8. Circulation. 2002 Dec 3;106(23):2871-2 - PubMed
  9. Int J Cardiol. 2016 Jul 15;215:20-2 - PubMed
  10. Circulation. 2012 Oct 16;126(16):2020-35 - PubMed
  11. Health Technol Assess. 2013;17(1):v-vi, 1-188 - PubMed
  12. Clin Chim Acta. 2015 Jan 1;438:376-81 - PubMed
  13. Clin Chem. 2014 Jan;60(1):158-64 - PubMed
  14. Circulation. 2015 Jun 9;131(23):2032-40 - PubMed
  15. Clin Biochem. 2015 Mar;48(4-5):201-3 - PubMed
  16. Acad Emerg Med. 2009 Jul;16(7):617-25 - PubMed
  17. BMJ. 2015 Jan 21;350:g7873 - PubMed
  18. Semin Thromb Hemost. 2014 Jul;40(5):535-43 - PubMed
  19. Eur Heart J. 2000 Sep;21(17):1406-32 - PubMed
  20. Clin Chem. 2015 Apr;61(4):646-56 - PubMed
  21. NCHS Data Brief. 2010 Sep;(43):1-8 - PubMed
  22. Clin Chem Lab Med. 2015 Apr;53(5):631-3 - PubMed
  23. Clin Res Cardiol. 2014 Mar;103(3):211-22 - PubMed
  24. Ann Transl Med. 2016 May;4(10):191 - PubMed
  25. Eur Heart J. 2011 Dec;32(23):2999-3054 - PubMed
  26. Clin Chim Acta. 2016 Jul 1;458:68-71 - PubMed
  27. Acad Emerg Med. 2009 Jan;16(1):1-10 - PubMed
  28. Eur Heart J. 2016 Jan 14;37(3):267-315 - PubMed
  29. N Engl J Med. 1997 Dec 4;337(23):1648-53 - PubMed
  30. N Engl J Med. 2000 Jul 6;343(1):8-15 - PubMed
  31. Clin Chem. 2012 Nov;58(11):1574-81 - PubMed
  32. Biomarkers. 2013 Dec;18(8):668-72 - PubMed
  33. Eur Heart J. 2016 Jan 1;37(1):24-34 - PubMed
  34. Clin Chem Lab Med. 2015 Apr;53(5):699-706 - PubMed
  35. J Prev Med Hyg. 2010 Dec;51(4):157-63 - PubMed
  36. Ann Transl Med. 2016 May;4(10):194 - PubMed
  37. J Am Coll Cardiol. 2010 May 11;55(19):2125-8 - PubMed
  38. Clin Chem. 2012 Dec;58(12):1665-72 - PubMed
  39. Nat Rev Cardiol. 2016 Jan;13(1):9-10 - PubMed
  40. Int J Cardiol. 2015;187:256-63 - PubMed
  41. Heart. 2005 Feb;91(2):229-30 - PubMed
  42. Am J Med. 2015 Aug;128(8):861-870.e4 - PubMed
  43. Lancet. 2015 Dec 19;386(10012):2481-8 - PubMed
  44. Clin Lab Med. 2014 Mar;34(1):59-73, vi - PubMed
  45. Circulation. 2016 Mar 1;133(9):916-47 - PubMed
  46. CJEM. 2006 Jan;8(1):27-31 - PubMed
  47. Circulation. 2000 Sep 5;102(10):1193-209 - PubMed
  48. Eur J Clin Invest. 1987 Aug;17(4):317-24 - PubMed
  49. N Engl J Med. 2005 Aug 18;353(7):671-82 - PubMed
  50. Ann Transl Med. 2016 May;4(10):193 - PubMed
  51. Scand J Clin Lab Invest. 2014 Jun;74(4):273-7 - PubMed
  52. Expert Rev Cardiovasc Ther. 2013 Sep;11(9):1129-39 - PubMed
  53. Eur Heart J. 2012 Sep;33(18):2252-7 - PubMed
  54. Ann Transl Med. 2016 May;4(10):187 - PubMed
  55. Am J Cardiol. 2013 Dec 15;112(12):1985 - PubMed
  56. JAMA Cardiol. 2016 Jul 1;1(4):405-12 - PubMed
  57. Clin Chem. 2012 Jan;58(1):54-61 - PubMed
  58. Heart. 2016 Aug 15;102(16):1270-8 - PubMed
  59. JAMA. 2011 Dec 28;306(24):2684-93 - PubMed

Publication Types